NO20064874L - Kontrollert frigivelses farmasoytisk sammensetning og metode for fremstilling av samme - Google Patents
Kontrollert frigivelses farmasoytisk sammensetning og metode for fremstilling av sammeInfo
- Publication number
- NO20064874L NO20064874L NO20064874A NO20064874A NO20064874L NO 20064874 L NO20064874 L NO 20064874L NO 20064874 A NO20064874 A NO 20064874A NO 20064874 A NO20064874 A NO 20064874A NO 20064874 L NO20064874 L NO 20064874L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- release pharmaceutical
- controlled release
- preparation
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Det er en hensikt ved den foreliggende, oppfinnelsen i forbindelse med en farmasøytisk sammensetning med kontrollert frigjøring, da spesielt en farmasøytisk med pulserende frigjøring, og som inneholder et syreustabilt fysiologisk aktivt stoff å tilveiebringe en farmasøytisk sammensetning med liten variasjon i oppløsningsforsinkelsestid og meget pålitelige oppløsningsegenskaper. Den foreliggende oppfinnelsen beskriver en farmasøytisk sammensetning med kontrollert frigjøring som omfatter (1) en kjerne som inneholder et syreustabilt fysiologisk aktivt stoff og et nedbrytningsmiddel og (2) et frigjøringskontrollerende lag som dekker kjernen og som inneholder en vannuløselig polymere, en enterisk polymer og en hydrofob voks.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004093506 | 2004-03-26 | ||
PCT/JP2005/005217 WO2005092336A1 (ja) | 2004-03-26 | 2005-03-23 | 溶出制御製剤とその製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20064874L true NO20064874L (no) | 2006-12-19 |
Family
ID=35055974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20064874A NO20064874L (no) | 2004-03-26 | 2006-10-26 | Kontrollert frigivelses farmasoytisk sammensetning og metode for fremstilling av samme |
Country Status (17)
Country | Link |
---|---|
US (2) | US20080095839A1 (no) |
EP (1) | EP1728512A1 (no) |
JP (1) | JPWO2005092336A1 (no) |
KR (1) | KR100794078B1 (no) |
CN (1) | CN1938026A (no) |
AU (1) | AU2005225283B2 (no) |
BR (1) | BRPI0509135A (no) |
CA (1) | CA2557791C (no) |
IL (1) | IL177087A (no) |
MX (1) | MXPA06010785A (no) |
MY (1) | MY139427A (no) |
NO (1) | NO20064874L (no) |
NZ (1) | NZ549838A (no) |
RU (1) | RU2337687C2 (no) |
TW (1) | TW200602085A (no) |
WO (1) | WO2005092336A1 (no) |
ZA (1) | ZA200607603B (no) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050163846A1 (en) * | 2001-11-21 | 2005-07-28 | Eisai Co., Ltd. | Preparation composition containing acid-unstable physiologically active compound, and process for producing same |
BRPI0509135A (pt) * | 2004-03-26 | 2007-08-28 | Eisai R&D Man Co Ltd | composição farmacêutica de liberação controlada e método para produzir a mesma |
JP5563735B2 (ja) | 2004-06-16 | 2014-07-30 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | Ppi多回剤形 |
US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
JP2008525313A (ja) | 2004-12-27 | 2008-07-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬の安定化方法 |
WO2007037259A1 (ja) * | 2005-09-29 | 2007-04-05 | Eisai R & D Management Co., Ltd. | 生体内での崩壊性を向上させたパルス製剤 |
EP1872778A1 (en) * | 2006-06-29 | 2008-01-02 | LEK Pharmaceuticals D.D. | Stable pharmaceutical composition with rabeprazole sodium |
DE102006035549A1 (de) * | 2006-07-27 | 2008-01-31 | Evonik Röhm Gmbh | Arzneiform mit mindestens zweischichtiger Trennschicht |
WO2008015530A2 (en) * | 2006-08-03 | 2008-02-07 | Aurobindo Pharma Limited | Stable solid oral formulation of pantoprazole |
WO2008062320A2 (en) | 2006-10-06 | 2008-05-29 | Eisai R&D Management Co., Ltd | Extended release formulations of a proton pump inhibitor |
PL2187873T3 (pl) | 2007-08-13 | 2019-01-31 | Abuse Deterrent Pharmaceutical Llc | Leki odporne na nadużywanie, metoda stosowania i metoda wytwarzania |
JP2009191036A (ja) * | 2008-02-15 | 2009-08-27 | Ss Pharmaceut Co Ltd | 時限放出製剤 |
JP2009191034A (ja) * | 2008-02-15 | 2009-08-27 | Ss Pharmaceut Co Ltd | 時限放出製剤 |
JP4864024B2 (ja) * | 2008-02-15 | 2012-01-25 | エスエス製薬株式会社 | 時限放出製剤 |
EP2255794A1 (en) * | 2009-05-29 | 2010-12-01 | H e x a l Aktiengesellschaft | Enteric coating |
JP5503192B2 (ja) * | 2009-06-03 | 2014-05-28 | 大原薬品工業株式会社 | 生理活性物質含有粒子の製造方法 |
KR20120047243A (ko) * | 2009-07-30 | 2012-05-11 | 에보니크 룀 게엠베하 | 음이온 중합체 물질 및 6 내지 22 개의 탄소 원자를 가지는 포화 모노카르복실산의 염을 포함하는 조성물 |
US8962020B2 (en) * | 2012-07-26 | 2015-02-24 | Glycadia Inc. | Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid |
JP2014122328A (ja) * | 2012-11-22 | 2014-07-03 | Shin Etsu Chem Co Ltd | 押出成形機又は射出成形機洗浄用組成物及び押出成形機又は射出成形機の洗浄方法 |
US11571390B2 (en) | 2013-03-15 | 2023-02-07 | Othemo Life Sciences, Inc. | Abuse deterrent compositions and methods of use |
CN103976972B (zh) * | 2014-05-26 | 2017-09-12 | 中国药科大学 | 酒石酸唑吡坦口服脉冲控释给药***及其制备方法 |
US10729685B2 (en) | 2014-09-15 | 2020-08-04 | Ohemo Life Sciences Inc. | Orally administrable compositions and methods of deterring abuse by intranasal administration |
CA2992356C (en) | 2015-07-17 | 2024-02-13 | BE Pharbel Manufacturing | Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form |
EP3117824A1 (en) | 2015-07-17 | 2017-01-18 | BE Pharbel Manufacturing | Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form |
CN105796532B (zh) * | 2016-03-28 | 2018-12-21 | 中国医药集团总公司四川抗菌素工业研究所 | 一种雷贝拉唑钠缓释胶囊及其制备方法 |
KR20210094513A (ko) * | 2018-11-19 | 2021-07-29 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 알코올-내성 약물 제형 |
KR20210071242A (ko) * | 2019-12-06 | 2021-06-16 | 진양제약주식회사 | 제약 조성물 |
CN113069428B (zh) * | 2021-04-02 | 2023-02-10 | 珠海润都制药股份有限公司 | 一种雷贝拉唑钠肠溶片的制备方法 |
KR102647279B1 (ko) | 2021-04-08 | 2024-03-18 | 대한뉴팜(주) | 라베프라졸의 우수한 방출 특성을 갖는 라베프라졸 나트륨 및 산화마그네슘을 포함하는 제제 및 이의 제조방법 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
JPS5846019A (ja) * | 1981-09-14 | 1983-03-17 | Kanebo Ltd | 持続性ニフエジピン製剤 |
US4863744A (en) * | 1984-09-17 | 1989-09-05 | Alza Corporation | Intestine drug delivery |
US4892742A (en) * | 1985-11-18 | 1990-01-09 | Hoffmann-La Roche Inc. | Controlled release compositions with zero order release |
JPH0768125B2 (ja) * | 1988-05-18 | 1995-07-26 | エーザイ株式会社 | 酸不安定化合物の内服用製剤 |
DE3822095A1 (de) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | Neue arzneimittelformulierung sowie verfahren zu deren herstellung |
US5229131A (en) * | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
KR930006431B1 (ko) * | 1990-10-11 | 1993-07-16 | 재단법인 한국화학연구소 | 약물의 미세캡슐화 방법 |
YU48263B (sh) * | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
FR2692146B1 (fr) * | 1992-06-16 | 1995-06-02 | Ethypharm Sa | Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention. |
US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
US6156343A (en) * | 1994-12-27 | 2000-12-05 | Akzo Nobel N.V. | Controlled release preparation |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
ES2137862B1 (es) * | 1997-07-31 | 2000-09-16 | Intexim S A | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. |
US6296876B1 (en) * | 1997-10-06 | 2001-10-02 | Isa Odidi | Pharmaceutical formulations for acid labile substances |
SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
CA2323680C (en) * | 1998-05-18 | 2007-05-22 | Takeda Chemical Industries, Ltd. | Orally disintegrable tablets |
JP2000128779A (ja) * | 1998-10-20 | 2000-05-09 | Mitsui Chemicals Inc | 薬物放出制御型製剤 |
SE9803772D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Pharmaceutical formulation |
US6183766B1 (en) * | 1999-02-12 | 2001-02-06 | The Procter & Gamble Company | Skin sanitizing compositions |
US6174902B1 (en) * | 1999-04-28 | 2001-01-16 | Sepracor Inc. | R-rabeprazole compositions and methods |
JP2001055322A (ja) * | 1999-08-18 | 2001-02-27 | Tanabe Seiyaku Co Ltd | パルス放出型製剤 |
US6369087B1 (en) * | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
DK1222922T3 (da) * | 1999-10-20 | 2007-12-03 | Eisai R&D Man Co Ltd | Fremgangsmåde til stabilisering af benzimidazolforbindelser |
US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
US20020045184A1 (en) * | 2000-10-02 | 2002-04-18 | Chih-Ming Chen | Packaging system |
US20050163846A1 (en) * | 2001-11-21 | 2005-07-28 | Eisai Co., Ltd. | Preparation composition containing acid-unstable physiologically active compound, and process for producing same |
AP1919A (en) * | 2001-11-21 | 2008-11-13 | Eisai R&D Man Co Ltd | Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same |
UA75831C2 (en) * | 2002-04-29 | 2006-05-15 | Egyt Gyogyszervegyeszeti Gyar | Process for preparation of tablets from pharmaceutically active ingredients having unfavourable tabletting properties with the use of granulating liquid containing microcrystalline cellulose |
CN1964704A (zh) * | 2004-03-03 | 2007-05-16 | 特瓦制药工业有限公司 | 包含酸不稳定药物的稳定药用组合物 |
BRPI0509135A (pt) * | 2004-03-26 | 2007-08-28 | Eisai R&D Man Co Ltd | composição farmacêutica de liberação controlada e método para produzir a mesma |
WO2007037259A1 (ja) * | 2005-09-29 | 2007-04-05 | Eisai R & D Management Co., Ltd. | 生体内での崩壊性を向上させたパルス製剤 |
-
2005
- 2005-03-23 BR BRPI0509135-7A patent/BRPI0509135A/pt not_active IP Right Cessation
- 2005-03-23 EP EP05727021A patent/EP1728512A1/en not_active Withdrawn
- 2005-03-23 MX MXPA06010785A patent/MXPA06010785A/es active IP Right Grant
- 2005-03-23 WO PCT/JP2005/005217 patent/WO2005092336A1/ja active Application Filing
- 2005-03-23 CN CNA2005800098028A patent/CN1938026A/zh active Pending
- 2005-03-23 RU RU2006134052/15A patent/RU2337687C2/ru not_active IP Right Cessation
- 2005-03-23 NZ NZ549838A patent/NZ549838A/en unknown
- 2005-03-23 US US10/594,436 patent/US20080095839A1/en not_active Abandoned
- 2005-03-23 JP JP2006511471A patent/JPWO2005092336A1/ja active Pending
- 2005-03-23 KR KR1020067019778A patent/KR100794078B1/ko not_active IP Right Cessation
- 2005-03-23 CA CA2557791A patent/CA2557791C/en not_active Expired - Fee Related
- 2005-03-23 AU AU2005225283A patent/AU2005225283B2/en not_active Ceased
- 2005-03-23 MY MYPI20051259A patent/MY139427A/en unknown
- 2005-03-24 TW TW094109169A patent/TW200602085A/zh unknown
-
2006
- 2006-07-25 IL IL177087A patent/IL177087A/en not_active IP Right Cessation
- 2006-09-11 ZA ZA200607603A patent/ZA200607603B/en unknown
- 2006-10-06 US US11/543,991 patent/US20120003311A9/en not_active Abandoned
- 2006-10-26 NO NO20064874A patent/NO20064874L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200602085A (en) | 2006-01-16 |
KR100794078B1 (ko) | 2008-01-10 |
KR20060134124A (ko) | 2006-12-27 |
ZA200607603B (en) | 2007-05-30 |
RU2006134052A (ru) | 2008-04-10 |
RU2337687C2 (ru) | 2008-11-10 |
CA2557791C (en) | 2011-03-08 |
US20120003311A9 (en) | 2012-01-05 |
IL177087A0 (en) | 2006-12-10 |
CN1938026A (zh) | 2007-03-28 |
JPWO2005092336A1 (ja) | 2008-02-07 |
CA2557791A1 (en) | 2005-10-06 |
AU2005225283A1 (en) | 2005-10-06 |
MY139427A (en) | 2009-09-30 |
MXPA06010785A (es) | 2007-03-28 |
AU2005225283B2 (en) | 2008-09-18 |
IL177087A (en) | 2011-11-30 |
BRPI0509135A (pt) | 2007-08-28 |
US20070110806A1 (en) | 2007-05-17 |
EP1728512A1 (en) | 2006-12-06 |
NZ549838A (en) | 2010-04-30 |
WO2005092336A1 (ja) | 2005-10-06 |
US20080095839A1 (en) | 2008-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20064874L (no) | Kontrollert frigivelses farmasoytisk sammensetning og metode for fremstilling av samme | |
US6117453A (en) | Solid compositions containing polyethylene oxide and an active ingredient | |
AU2004208606B2 (en) | Process for producing coated preparation | |
CA2348086C (en) | Controlled-release pharmaceutical formulations | |
RU99126869A (ru) | Фармацевтический препарат омепразола | |
RU2006101082A (ru) | Фармацевтическая композиция с набухающим покрытием | |
JP4286452B2 (ja) | 胃において保護されるオメプラゾール微粒子、その製造方法および医薬製剤 | |
BRPI0409652A (pt) | tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete | |
WO2007054976A3 (en) | Lipid based controlled release pharmaceutical composition | |
MY151470A (en) | Controlled release solid preparation | |
IL151150A0 (en) | Multiparticulate drug form comprising at least two differently coated pellet forms | |
RU2007115537A (ru) | Новые препараты ингибиторов протонного насоса в виде пеллет с модифицированным высвобождением | |
WO2008000731A2 (en) | Pharmaceutical composition for the oral administration of omega polyenoic fatty acids | |
NO20092662L (no) | Sammensetning med forlenget frigjoring og fremgangsmate for a produsere det samme | |
CA2566497A1 (en) | Multi-layered controlled-release methylphenidate pellet | |
GEP20043285B (en) | Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections | |
CA2595409A1 (en) | Oral dosage form comprising rosiglitazone | |
JP2014533656A5 (no) | ||
KR20100008356A (ko) | 칼슘채널길항제를 포함하는 약제학적 제제 | |
NO20031409L (no) | Ionestyrkeuavhengig farmasoytiske preparat med langvarig frigivelse | |
JP2019509345A5 (no) | ||
CN108338976A (zh) | 一种硝苯地平双层渗透泵片及其制备方法 | |
NO20075715L (no) | Depotsammensetning omfattende cefalosporin for behandling av en bakterieinfeksjon | |
NO20052960L (no) | Anvendelse av dokosahekasensyre som aktivt stoff til behandling av lipodystrofi | |
NO331643B1 (no) | Mikrogranuler som ikke er loselige i magesaft, fremgangsmater for a oppna det samme og farmasoytiske preparater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |